Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05430230 · ClinicalTrials.gov registry record · Phase 4
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
A Phase 4 study of Osteoarthritis, Knee, sponsored by Northwestern University.
- Active
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05430230: Active Phase 4 study of Osteoarthritis, Knee, sponsored by Northwestern University.
NCT05430230 is a Phase 4 study of Osteoarthritis, Knee that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 20 participants, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05430230, a Phase 4 study of Osteoarthritis, Knee, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study with a 4-period double-cross-over design evaluating a treatment with non-steroidal anti-inflammatory drugs (NSAIDs) in people with painful knee osteoarthritis.
Primary Outcome
daily pain will be collected by a web application and averaged over a 7day period; higher scores imply more pain
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Naproxen 500 Mg
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-08-24 |
| Est. Completion | 2027-09-01 |
| Phase | Phase 4 |
What the registry record for NCT05430230 still lists
NCT05430230 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05430230 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05430230 about?
NCT05430230 is a clinical study titled "Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis". This is a pilot study with a 4-period double-cross-over design evaluating a treatment with non-steroidal anti-inflammatory drugs (NSAIDs) in people with painful knee osteoarthritis.
What is the current status of trial NCT05430230?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2022-08-24. Estimated completion is 2027-09-01.
What conditions does trial NCT05430230 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT05430230?
The interventions under investigation include: Placebo (DRUG), Naproxen 500 Mg (DRUG).
Who is sponsoring clinical trial NCT05430230?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05430230 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05430230's enrollment target sits among peer trials
20 106th of 112 higher than 6 of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Triamcinolone Ketorolac (TriKe) Knee Trial
RECRUITING · Phase 4
-
Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes
RECRUITING · Phase 4
-
ZYNRELEF for Pain Management in Total Knee Arthroplasty
RECRUITING · Phase 4
-
Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty
RECRUITING · Phase 4
-
Corticosteroid Meniscectomy Randomized Trial
ACTIVE NOT RECRUITING · Phase 4
-
Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI